18/03/2016

Global platform to inform investments for health R&D

The Lancet "Investments in health research and development (R&D) are still insufficiently aligned with global public health demands and needs. As little as 1% of all global funding for health R&D is allocated to diseases mostly noted in low-income and middle-income countries, such as malaria and tuberculosis, even though these diseases account for more than 12·5% of the global burden of disease. (...)